Hainan Shuangcheng Pharmaceut - Asset Resilience Ratio

Latest as of March 2026: 1.03%

Hainan Shuangcheng Pharmaceut (002693) has an Asset Resilience Ratio of 1.03% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥8.41 Million
≈ $1.23 Million USD Cash + Short-term Investments

Total Assets

CN¥816.14 Million
≈ $119.43 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2014–2025)

This chart shows how Hainan Shuangcheng Pharmaceut's Asset Resilience Ratio has changed over time. Check Hainan Shuangcheng Pharmaceut strategic asset allocation index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Hainan Shuangcheng Pharmaceut's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 002693 company net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥8.41 Million 1.03%
Total Liquid Assets CN¥8.41 Million 1.03%

Asset Resilience Insights

  • Limited Liquidity: Hainan Shuangcheng Pharmaceut maintains only 1.03% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Hainan Shuangcheng Pharmaceut Industry Peers by Asset Resilience Ratio

Compare Hainan Shuangcheng Pharmaceut's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
Drug Manufacturers - Specialty & Generic 3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd
SHG:688621
Drug Manufacturers - Specialty & Generic 2.04%
Guizhou Xinbang Pharmaceutical Co Ltd
SHE:002390
Drug Manufacturers - Specialty & Generic 0.01%
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111
Drug Manufacturers - Specialty & Generic 7.85%
Jw Pharmac
KO:001060
Drug Manufacturers - Specialty & Generic 3.65%
Kamada
TA:KMDA
Drug Manufacturers - Specialty & Generic 0.00%
Samjin Pharm
KO:005500
Drug Manufacturers - Specialty & Generic 0.25%

Annual Asset Resilience Ratio for Hainan Shuangcheng Pharmaceut (2014–2025)

The table below shows the annual Asset Resilience Ratio data for Hainan Shuangcheng Pharmaceut.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.01% CN¥46.43K
≈ $6.79K
CN¥825.78 Million
≈ $120.84 Million
+0.01pp
2024-12-31 0.00% CN¥2.83K
≈ $413.53
CN¥783.87 Million
≈ $114.70 Million
-3.55pp
2023-12-31 3.55% CN¥28.52 Million
≈ $4.17 Million
CN¥803.25 Million
≈ $117.54 Million
-11.14pp
2022-12-31 14.69% CN¥133.81 Million
≈ $19.58 Million
CN¥911.02 Million
≈ $133.31 Million
+8.20pp
2021-12-31 6.48% CN¥55.40 Million
≈ $8.11 Million
CN¥854.56 Million
≈ $125.05 Million
-3.90pp
2020-12-31 10.38% CN¥94.25 Million
≈ $13.79 Million
CN¥907.68 Million
≈ $132.82 Million
+4.83pp
2019-12-31 5.55% CN¥52.80 Million
≈ $7.73 Million
CN¥950.98 Million
≈ $139.16 Million
-6.94pp
2018-12-31 12.50% CN¥139.98 Million
≈ $20.48 Million
CN¥1.12 Billion
≈ $163.93 Million
+1.80pp
2017-12-31 10.69% CN¥147.25 Million
≈ $21.55 Million
CN¥1.38 Billion
≈ $201.52 Million
+10.26pp
2016-12-31 0.43% CN¥5.00 Million
≈ $731.66K
CN¥1.17 Billion
≈ $170.55 Million
+0.21pp
2015-12-31 0.22% CN¥3.37 Million
≈ $493.14K
CN¥1.55 Billion
≈ $226.84 Million
-40.06pp
2014-12-31 40.27% CN¥380.00 Million
≈ $55.61 Million
CN¥943.54 Million
≈ $138.07 Million
--
pp = percentage points

About Hainan Shuangcheng Pharmaceut

SHE:002693 China Drug Manufacturers - Specialty & Generic
Market Cap
$533.40 Million
CN¥3.65 Billion CNY
Market Cap Rank
#11750 Global
#3312 in China
Share Price
CN¥8.79
Change (1 day)
+2.33%
52-Week Range
CN¥6.52 - CN¥11.61
All Time High
CN¥38.37
About

Hainan Shuangcheng Pharmaceuticals Co., Ltd. engages in research and development, production, and sale of pharmaceutical injections, solid preparations, and raw materials in China and internationally. The company offers products for oncology and immune, alimentary canal, heart and cerebral, and vessels and metabolism. It also provides Bivalirudin, Epitifibatide, and Thymalfaxin for injection; Pre… Read more